Morgan Stanley’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-15,334
| Closed | -$2.68K | – | 7831 |
|
|
2023
Q1 | $2.68K | Sell |
15,334
-1,717
| -10% | -$300 | ﹤0.01% | 7186 |
|
|
2022
Q4 | $6.78K | Sell |
17,051
-16,048
| -48% | -$6.38K | ﹤0.01% | 7066 |
|
|
2022
Q3 | $26K | Buy |
33,099
+1,493
| +5% | +$1.17K | ﹤0.01% | 6683 |
|
|
2022
Q2 | $90K | Buy |
31,606
+7,147
| +29% | +$20.4K | ﹤0.01% | 6334 |
|
|
2022
Q1 | $153K | Buy |
24,459
+1,932
| +9% | +$12.1K | ﹤0.01% | 6065 |
|
|
2021
Q4 | $251K | Sell |
22,527
-9,920
| -31% | -$111K | ﹤0.01% | 5947 |
|
|
2021
Q3 | $529K | Buy |
32,447
+4,229
| +15% | +$68.9K | ﹤0.01% | 5459 |
|
|
2021
Q2 | $523K | Sell |
28,218
-772
| -3% | -$14.3K | ﹤0.01% | 5495 |
|
|
2021
Q1 | $437K | Sell |
28,990
-1,512
| -5% | -$22.8K | ﹤0.01% | 5230 |
|
|
2020
Q4 | $986K | Buy |
+30,502
| New | +$986K | ﹤0.01% | 4676 |
|